Velos Communications – Terumo BCT Partners with StafaCT

Fremont, CA – March 8, 2018

Velos is pleased to announce that Terumo BCT is now StafaCT’s partner in Apheresis, Cell Therapy, and Transplant. StafaCT is the Velos subsidiary focused on software for cell therapy. This collaboration was announced on February 24 at the Bone Marrow Transplant (BMT) Tandem 2018 conference, which is jointly hosted by ASBMT (American Society for Blood and Marrow Transplantation) and CIBMTR (Center for International Blood and Marrow Transplant Research).

Terumo BCT is a subsidiary of Terumo. Terumo has over $5 billion in annual revenues in the medical device, services, and technology business.

Terumo BCT will provide exclusive worldwide marketing, sales, and support for StafaCT products. Terumo BCT has deep roots in the cell therapy world. Its knowledge of this domain, experienced teams, and global reach will allow us to deliver a high-quality Stafa experience to our cell therapy customer and partner community.

The StafaCT team will focus on its core strength in software product development and cloud hosting and will be working with our customer-partners, scientific advisors, and engineers to deliver our exciting products to the world of cell therapy. Terumo Apheresis machines (Spectra Optia and others) will be integrated with StafaCT software on-premise or from the cloud.

Many Velos customers have significant cell therapy departments and initiatives. StafaCT eagerly looks forward to helping your organization with your cell therapy mission!

You can read about the collaboration here: Terumo Press Release.

About Velos:
Velos is the trusted clinical trial management resource for investigators, sponsors, and academic leaders throughout the world. Velos integrates the clinical, administrative, and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California. For more information, visit www.velos.com